|
Volumn 44, Issue 1, 2012, Pages 264-266
|
The clinical significance of human leukocyte antigen antibody development in kidney transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
HLA ANTIBODY;
MYCOPHENOLIC ACID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
CONFERENCE PAPER;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY;
HLA ANTIGENS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
ISOANTIBODIES;
KIDNEY TRANSPLANTATION;
ODDS RATIO;
RETROSPECTIVE STUDIES;
RISK ASSESSMENT;
RISK FACTORS;
TAIWAN;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 84863355769
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2011.11.037 Document Type: Conference Paper |
Times cited : (2)
|
References (6)
|